Cormorant Asset Management, LLC Buys Forma Therapeutics Holdings Inc, Avidity Biosciences Inc, Immunovant Inc, Sells Principia Biopharma Inc, Mirati Therapeutics Inc, Satsuma Pharmaceuticals Inc

• New Purchases: FMTX, RNA, IMVT, TRIL, ALBO, OTIC, TCRR, TARA, MORF, CRDF,
• Added Positions: ZYME, OMER, BNTX, AKRO, TBPH, RETA, GLPG, VIE,
• Reduced Positions: MRTX, TPTX, CCXI, MYOK, BBIO, AGEN, XLRN, ALLK, IGMS, AXSM, YMAB, ASND, BHVN, MYOV, CRSP, ARGX, QTNT, APLS, BPMC, QURE, ANAB, ZLAB, ARCT, DCPH, TCDA, KDMN, SRPT, STOK, KURA, SRNE, INSM, ARNA, EIDX, MRUS, TWST, EIGR, INSP, AMRN, RCKT, KZR, AVEO, NKTR, AVRO, FIXX, GOSS, HARP, FATE, AUTL, AXNX, NERV, BCEL, CABA, RPTX,
• Sold Out: PRNB, STSA, NXTC, ARYBU, XFOR,

For the details of Cormorant Asset Management, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/cormorant+asset+management%2C+llc/current-portfolio/portfolio

1. Turning Point Therapeutics Inc (TPTX) - 2,442,297 shares, 8.46% of the total portfolio. Shares reduced by 10.78%
2. SSGA SPDR S&P 500 (SPY) - 500,000 shares, 6.64% of the total portfolio.
3. Forma Therapeutics Holdings Inc (FMTX) - 3,379,373 shares, 6.60% of the total portfolio. New Position
4. Revolution Medicines Inc (RVMD) - 2,640,177 shares, 3.64% of the total portfolio. Shares added by 0.13%
5. BridgeBio Pharma Inc (BBIO) - 2,265,762 shares, 3.37% of the total portfolio. Shares reduced by 12.54%

Cormorant Asset Management, LLC initiated holding in Forma Therapeutics Holdings Inc. The purchase prices were between $32.95 and $50.25, with an estimated average price of $40.52. The stock is now traded at around $38.420000. The impact to a portfolio due to this purchase was 6.6%. The holding were 3,379,373 shares as of 2020-09-30.

Cormorant Asset Management, LLC initiated holding in Avidity Biosciences Inc. The purchase prices were between $23.35 and $35.94, with an estimated average price of $28.87. The stock is now traded at around $29.850000. The impact to a portfolio due to this purchase was 2.76%. The holding were 2,514,546 shares as of 2020-09-30.

Cormorant Asset Management, LLC initiated holding in Immunovant Inc. The purchase prices were between $22.61 and $38.9, with an estimated average price of $30.07. The stock is now traded at around $49.560000. The impact to a portfolio due to this purchase was 2.28%. The holding were 1,637,951 shares as of 2020-09-30.

Cormorant Asset Management, LLC initiated holding in Trillium Therapeutics Inc. The purchase prices were between $6.56 and $16, with an estimated average price of $9.93. The stock is now traded at around $12.030000. The impact to a portfolio due to this purchase was 1.41%. The holding were 2,500,000 shares as of 2020-09-30.

Cormorant Asset Management, LLC initiated holding in Albireo Pharma Inc. The purchase prices were between $23.19 and $41.61, with an estimated average price of $29.06. The stock is now traded at around $39.780000. The impact to a portfolio due to this purchase was 0.93%. The holding were 700,000 shares as of 2020-09-30.

Cormorant Asset Management, LLC initiated holding in Otonomy Inc. The purchase prices were between $3.16 and $4.36, with an estimated average price of $3.76. The stock is now traded at around $6.010000. The impact to a portfolio due to this purchase was 0.52%. The holding were 3,241,800 shares as of 2020-09-30.

Cormorant Asset Management, LLC added to a holding in Zymeworks Inc by 109.09%. The purchase prices were between $29.21 and $46.58, with an estimated average price of $34.32. The stock is now traded at around $53.050000. The impact to a portfolio due to this purchase was 1.11%. The holding were 1,150,000 shares as of 2020-09-30.

Cormorant Asset Management, LLC added to a holding in Omeros Corp by 80.18%. The purchase prices were between $9.57 and $21.32, with an estimated average price of $12.87. The stock is now traded at around $14.660000. The impact to a portfolio due to this purchase was 0.89%. The holding were 5,000,000 shares as of 2020-09-30.

Cormorant Asset Management, LLC added to a holding in BioNTech SE by 85.71%. The purchase prices were between $57.81 and $104.17, with an estimated average price of $71.42. The stock is now traded at around $100.560000. The impact to a portfolio due to this purchase was 0.41%. The holding were 325,000 shares as of 2020-09-30.

Cormorant Asset Management, LLC added to a holding in Akero Therapeutics Inc by 45.06%. The purchase prices were between $30.79 and $39.92, with an estimated average price of $34.88. The stock is now traded at around $26.270000. The impact to a portfolio due to this purchase was 0.33%. The holding were 859,550 shares as of 2020-09-30.

Cormorant Asset Management, LLC added to a holding in Theravance Biopharma Inc by 550.07%. The purchase prices were between $14.79 and $22.49, with an estimated average price of $18.74. The stock is now traded at around $19.060000. The impact to a portfolio due to this purchase was 0.32%. The holding were 650,072 shares as of 2020-09-30.

Cormorant Asset Management, LLC added to a holding in Galapagos NV by 31.21%. The purchase prices were between $122.47 and $213.56, with an estimated average price of $166.57. The stock is now traded at around $97.930000. The impact to a portfolio due to this purchase was 0.17%. The holding were 130,000 shares as of 2020-09-30.

Cormorant Asset Management, LLC sold out a holding in Principia Biopharma Inc. The sale prices were between $56 and $101.07, with an estimated average price of $88.57.

Cormorant Asset Management, LLC sold out a holding in Satsuma Pharmaceuticals Inc. The sale prices were between $3.85 and $28.47, with an estimated average price of $20.25.

Cormorant Asset Management, LLC sold out a holding in NextCure Inc. The sale prices were between $8.15 and $21.17, with an estimated average price of $10.38.

Cormorant Asset Management, LLC sold out a holding in ARYA Sciences Acquisition Corp II. The sale prices were between $10.71 and $12.49, with an estimated average price of $11.34.

Cormorant Asset Management, LLC sold out a holding in X4 Pharmaceuticals Inc. The sale prices were between $6.09 and $9.15, with an estimated average price of $8.01.